Hence, we hypothesized that pharmacologically induced differentiation of neuroblastoma cells with retinoids depends on reprogramming of the adrenergic CRC, leading to rapid down-regulation of MYCN expression, even in the context of massive MYCN gene amplification. This evidence concerns the gene MYCN and neuroblastoma.